// App-Quantinova.ai

2120 : Molecular characterization of cancer stem cells derived from drug-resistant melanoma

Researchers

Presenter

  • Elyse J. Berlinberg

Principal Investigators

  • William Crosson

  • Arbis Rojas

  • Ramin Nazarian

Medical Centers

  • UCLA David Geffen School of Medicine, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Melanoma

  • Solid malignancies

Biomarkers

  • Mitogen-activated protein kinase

  • B-Raf proto-oncogene, serine/threonine kinase

Drug/Treatment

  • Vemurafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved